DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20170545

Camylofin in the management of prolonged labor: a review of evidence

N. Mayadeo, A. Gangadhar, Srirupa Das

Abstract


Prolonged labor can lead to increased maternal and neonatal morbidity and mortality. Hence, it warrants an early detection and appropriate clinical management. Active management of labor has shown to decrease the occurrence of prolonged labor. Administering antispasmodics during labor facilitates a faster and more effective dilatation of the cervix.  Hence, antispasmodics can be used to decrease the incidence of prolonged labor. Camylofin, a potent antispasmodic, with a dual mode of action, has been used in the augmentation of labor for more than six decades. There is a growing body of evidence to support the efficacy and tolerability of Camylofin in the active management of labor.  A review of published evidence suggests that Camylofin has superior efficacy in augmentation of labor on multiple counts like rate of cervical dilation, duration of active phase of first stage of labor and induction delivery interval, when compared to other spasmolytics like drotaverine, hyoscine and valethemate. It also has a benefit of a convenient single dose as compared to the other spasmolytics listed earlier. Camylofin has other advantages like a quick onset of action, prolonged action, no adverse effects on uterine contractility, no contraindication for use in uterine inertia cases and overall good tolerability for both mother and fetus. Given the superior efficacy and benefits that this drug exhibits, coupled with its excellent tolerability profile, Camylofin should be the first choice and may be preferred over other drugs for cervical dilatation and acceleration of active phase of labor.

Keywords


Active phase of labor, Camylofin, Cervical dilatation, Drotaverine, Hyoscine

Full Text:

PDF

References


Dayama SS, Patil SS, Sambarey PW. A randomised controlled study of intramuscular camylofin dihydrochloride vs intravenous hyoscine butylbromide in augmentation of labour. Global J Med Res: Gynecol Obstet. 2016;16(1):1-6.

Kaur S, Bajwa SK, Kaur P, Bhupal S. To compare the effect of camylofin dihydrochloride (anafortin) with combination of valethamate bromide (epidosin) and hyoscine butyl-n-bormide (buscopan) on cervical dilation. J Clin Diagn Res. 2013;7(9):1897-9.

Aziz M. Comparative study of tramadol hydrochloride and drotavarine hydrochloride on cervical dilatation in active labour. Int J Sci Tech Res. 2014;3(4):338-47.

Warke HS, Chauhan AR, Raut VS, Ingle KM, Efficacy of camylofin dihydrochloride in acceleration of labour. A randomised double blind trial. Bombay Hospital J. 2003;l.45(3)420-3.

Gabhane M, Braganza L, Das S, et al. Recommendation patterns by various practitioners in the treatment of colicky abdominal pain in India. IJCP. 2016;28(10):933-7.

Gabhane M, Braganza L. Preference trends for antispasmodics among Indian healthcare professionals. Results of a cross sectional survey. Indian Pract. 2015;28(10):32-7.

Rajani U, Binu P. A Randomized Comparative Study of Intramuscular Camylofin Dihydrochloride and Intravenous Drotaverine Hydrochloride on Cervical Dilatation in Labor. Indian J Clinical Practice. 2015;26(6):558-63.

Kaur S, Kaur P, Bajwa SK, Kumari S, Mohi MK. To evaluate the incidence of side effects of camylofindihydrochloride with combination of valethemate bromide (epidosin) and hyoscine- N - butyl bromide (Buscopan), on mother and to look for neonatal outcome. J Med Health Sci. 2013;l.2(4):33-7.

E B, Mutschler E, "Spasmolytics. In: Ullmann's Encyclopedia of Industrial Chemistry.Wiley, 2012;34:1-15.

Desai SN, Desai SV. Optimizing labour and delivery - use of the indigenous protocol. In: Selected topics in obstetrics and gynaecology-1 for postgraduates and practitioners. B I Publications; 2005:59-60.

Kaur D, Kaur A. “Anafortan” an old drug with its newer use in acceleration of labour [abstract]. 49th All India Congress of Obstetrics and Gynaecology; 2006 January 6-9; Cochin, Kerala State, India. 2006:59.

Drescher H. Experience with the spasmolyticum avacan in obstetrics]. Munch Med Wochenschr. 1954;96(40):11645.

Jann R. Experience with the spasmolytic avacan in obstetrics. Ther Umsch. 1954;11(4):802.